by GlobeNewsWire | Aug 1, 2016 | Globe Newswire
REDWOOD CITY, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today reported results for the second quarter ended June 30, 2016. Second...
by GlobeNewsWire | Aug 1, 2016 | Energy
TULSA, Aug. 01, 2016 (GLOBE NEWSWIRE) — Mid-Con Energy Partners, LP (NASDAQ:MCEP) (“Mid-Con Energy” or the “Partnership”) through its wholly owned subsidiary, Mid-Con Energy Properties, LLC, announces that on July 28, 2016 it has entered into a definitive...
by GlobeNewsWire | Aug 1, 2016 | Globe Newswire
IRVING, Texas, Aug. 01, 2016 (GLOBE NEWSWIRE) — International Western Petroleum, Inc. (OTCQB:INWP), a Texas-based E&P company specializing in the acquisition, development, and exploration of crude oil and natural gas properties, announced today that it has...
by GlobeNewsWire | Aug 1, 2016 | Globe Newswire
DURHAM, N.C., Aug. 01, 2016 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel antivirals in areas of high unmet medical need, today announced that it will host a live conference call and audio webcast on Monday, August...
by GlobeNewsWire | Aug 1, 2016 | Globe Newswire
FDA Approves Commencement of Phase III Pivotal Trial as Amended Requires Additional Validation of TcPO2 as a Surrogate to Support Subsequent PMA Approval RANCHO CORDOVA, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (NASDAQ:KOOL), an...